Population-based retrospective study to investigate preexisting and new depression diagnosis among head and neck cancer patients |
| |
| Institution: | 1. Department of Epidemiology, College of Public Health, University of Nebraska Medical Center, Omaha, NE, United States;2. Center for Collaboration on Research Design and Analysis, University of Nebraska Medical Center, Omaha, NE, United States;3. Department of Otolaryngology-Head and Neck Surgery, University of Nebraska Medical Center and Nebraska Methodist Hospital, Omaha, NE, United States;4. Department of Biostatistics, College of Public Health, University of Nebraska Medical Center, Omaha, NE, United States;5. College of Nursing, University of Nebraska Medical Center, Omaha, NE, United States;1. Sam Fayad Gastro-Intestinal Viral Oncology Group, Ingham Institute for Applied Medical Research, Liverpool, Sydney, New South Wales, 2170, Australia;2. South Western Sydney Clinical School, University of New South Wales, Liverpool, Sydney, New South Wales, 2170, Australia;3. Department of Gastroenterology & Hepatology, Bankstown-Lidcombe Hospital, South Western Sydney Local Health Network, Sydney, New South Wales 2200, Australia;1. Sam Fayad Gastro-Intestinal Viral Oncology Group, Ingham Institute for Applied Medical Research, Liverpool, Sydney, New South Wales, 2170, Australia;2. South Western Sydney Clinical School, University of New South Wales, Liverpool, Sydney, New South Wales, 2170, Australia;1. National Registry of Diseases Office, Singapore Cancer Registry, Health Promotion Board, 3 Second Hospital Avenue, Singapore 168937, Singapore;2. Saw Swee Hock School of Public Health, National University of Singapore, 12 Science Drive 2 #10-01 Singapore 117549, Singapore;1. Biostatistics Unit, Department of Basic Sciences, Universitat Internacional de Catalunya, Sant Cugat del Vallès, Spain;2. Plan for Oncology of the Catalan Government, L’Hospitalet de Llobregat, Spain;3. Department of Clinical Sciences, School of Medicine, Universitat de Barcelona, Barcelona, Spain;4. Centre Atenció Primària Les Corts. Transverse Group for Research in Primary Care, IDIBAPS, Barcelona, Spain;5. Public Health Unit, Department of Medicine, Universitat Internacional de Catalunya, Sant Cugat del Vallès, Spain;6. EPIUnit − Instituto de Saúde Pública da Universidade do Porto (ISPUP), Porto, Portugal;7. Department of Clinical Epidemiology, Predictive Medicine and Public Health, University of Porto Medical School, Porto, Portugal;8. Tobacco Control Unit, Cancer Prevention and Control Programme, Catalan Institute of Oncology-ICO, L''Hospitalet de Llobregat, Spain;9. Cancer Control and Prevention Group, Bellvitge Biomedical Research Institute-IDIBELL, L’Hospitalet de Llobregat, Spain;1. Johns Hopkins Bloomberg School of Public Health, 615 N Wolfe St., Baltimore, MD 21205, United States;2. German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany;3. Maimonides Medical Center, 4802 Tenth Avenue, Brooklyn, NY 11219, United States;4. University of Pittsburgh, 3520 Fifth Avenue, Pittsburgh, PA 15213, United States;5. University of California, Los Angeles, 2-256 Factor Bldg., Los Angeles, CA 90095-1702, United States;6. Albert Einstein College of Medicine, 1300 Morris Park Ave., Bronx, NY 10461, United States;7. Northwestern University, 645 N Michigan Ave., Chicago, IL 60611, United States;8. CORE Center at John H. Stroger Jr. Hospital of Cook County, 2225 W Harrison St., Chicago, IL 60612, United States;9. Ohio State University Comprehensive Cancer Center, 420 W 12th Ave., Columbus, OH 43210, United States;1. Cancer Council Queensland, PO Box 201, Spring Hill, QLD 4004, Australia;2. Menzies Health Institute Queensland, Griffith University, Gold Coast Campus, Parklands Drive, Southport, QLD 4222, Australia;3. School of Mathematical Sciences, Queensland University of Technology, ddGardens Point, Brisbane, QLD 4000, Australia;4. Menzies School of Health Research, Charles Darwin University, 147 Wharf Street, Spring Hill, QLD 4004, Australia;5. Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden;6. Systems, Policy and Planning Division, Queensland Health, 147-163 Charlotte Street, Brisbane, QLD 4000, Australia;1. Centre for Big Data Research in Health, University of New South Wales, Sydney, NSW, 2052, Australia;2. Faculty of Medicine and Health Science, Macquarie University, Sydney, NSW, 2109, Australia;3. Douglass Hanly Moir Pathology, Macquarie Park, NSW, 2113, Australia;4. Crown Princess Mary Cancer Centre, Westmead Hospital, Westmead, NSW, 2145, Australia;5. Cancer Therapy Centre, Liverpool Hospital, Liverpool, NSW, 2170, Australia |
| |
| Abstract: | This study aimed to estimate the pre-cancer prevalence and post-cancer incidence of depression in older adult head and neck cancer patients. Using SEER-Medicare files, cancer was identified from SEER data and depression diagnosis was identified using Medicare claims. Of 3533 head and neck cancer patients, 10.6% were diagnosed with depression during the two years prior to cancer diagnosis, and an additional 8.9% developed depression in the year following cancer diagnosis. This study supports the critical need of screening for depression throughout cancer diagnosis and treatment, as well as a preventative approach in depression development in the older head and neck cancer patient population. |
| |
| Keywords: | Depression Head and neck cancer SEER-Medicare Cancer Oncology Epidemiology |
| 本文献已被 ScienceDirect 等数据库收录！ |
|
